DelveInsight's Claudin 18.2 Directed Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

Neuroradiology is a pivotal field within medical imaging, focusing on the diagnosis and treatment of neurological disorders. As medical technology advances, ...

PSYPACT allows licensed psychologists to practice across state lines via telepsychology and temporary in-person services, ...

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising therapies in development, including calreticulin antibodies, selective JAK2 ...

Photo from NParks Aside from these gardens located at parks around Singapore, the agency plans to bring therapeutic landscapes closer to the community by introducing them within housing precincts.

The FDA has approved tafasitamab in combination with lenalidomide and rituximab for the treatment of adult patients with R/R FL. This regulatory decision marks an important addition to the therapeutic ...

How does this shift influence the therapeutic landscape, particularly the need for localized, low-toxicity interventions like intratumoral therapies? Weiss: The National Lung Screening Trial, along ...

The therapeutic landscape of small cell lung cancer (SCLC) is undergoing a paradigm shift with the emergence of delta-like ligand-3 (DLL3)–directed therapies, particularly tarlatamab, a first-in-class ...